Financials Haisco Pharmaceutical Group Co., Ltd.

Equities

002653

CNE100001BC7

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-07-21 pm EDT 5-day change 1st Jan Change
29.48 CNY +0.92% Intraday chart for Haisco Pharmaceutical Group Co., Ltd. -1.07% +27.34%

Compte de Résultat Prévisionnel: Haisco Pharmaceutical Group Co., Ltd.

Forecast Balance Sheet: Haisco Pharmaceutical Group Co., Ltd.

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Change - - - - - - - -
Announcement Date 2/28/20 2/26/21 4/26/22 4/17/23 4/19/24 - - -
Estimates

Cash Flow Forecast: Haisco Pharmaceutical Group Co., Ltd.

Fiscal Period: December 2020 2021 2023 2024 2025 2026
CAPEX 1 599.9 702.6 386.7 254.9 243.1 255
Change - 17.11% - -34.08% -4.65% 4.88%
Free Cash Flow (FCF) 1 - - - 99.7 318.5 751.3
Change - - - - 219.46% 135.89%
Announcement Date 2/26/21 4/26/22 4/19/24 - - -
1CNY in Million
Estimates

Forecast Financial Ratios: Haisco Pharmaceutical Group Co., Ltd.

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026

Profitability

        
EBITDA Margin (%) - 24.15% 24.95% - 15.77% 16.81% 19.37% 22.02%
EBIT Margin (%) - 20.74% 18.47% - 9.35% 12.84% 15.32% 17.63%
EBT Margin (%) - 20.62% 18.42% - 9.02% 12.79% 15.27% 17.57%
Net margin (%) - 18.53% 12.44% - 8.8% 11.6% 12.07% 15.71%
FCF / Net Income (%) - - - - - 2.48% 6.23% 11.52%

Profitability

        
ROA - - - - 4.65% 7.9% 7.9% 14.6%
ROE - 23.42% 12.3% - 9.19% 10.25% 12.49% 16.94%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) - 17.98% 25.33% - 11.53% 6.35% 4.75% 3.91%
CAPEX / EBITDA (%) - 74.44% 101.55% - 73.09% 37.75% 24.54% 17.76%
CAPEX / FCF (%) - - - - - 255.71% 76.33% 33.94%

Items per share

        
Cash flow per share 1 - 0.1919 0.0333 - 0.4035 0.385 0.45 0.81
Change - - -82.65% - - -4.58% 116.88% 180%
Dividend per Share 1 - - - - 0.2 0.03 0.08 0.06
Change - - - - - -85% 266.67% 75%
Book Value Per Share 1 - 2.71 2.64 - 3.752 4.093 4.412 5.437
Change - - -2.6% - - 9.1% 107.8% 123.21%
EPS 1 0.47 0.58 0.32 0.26 0.27 0.4167 0.5525 0.92
Change - 23.4% -44.83% -18.75% 3.85% 54.32% 132.6% 166.52%
Nbr of stocks (in thousands) 1,069,612 1,063,821 1,066,028 1,064,949 1,103,460 1,103,460 1,103,460 1,103,460
Announcement Date 2/28/20 2/26/21 4/26/22 4/17/23 4/19/24 - - -
1CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
29.48CNY
Average target price
36.19CNY
Spread / Average Target
+22.76%
Consensus
  1. Stock Market
  2. Equities
  3. 002653 Stock
  4. Financials Haisco Pharmaceutical Group Co., Ltd.